Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
about
Oncolytic parvoviruses: from basic virology to clinical applicationsGene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene.Current status of gene therapy for brain tumors.Chapter two--Adenovirus strategies for tissue-specific targeting.Oncolytic adenoviruses: A thorny path to glioma cureCritical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific AntigensComplex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMAPerspectives in vector development for systemic cancer gene therapy.Advances in immunotherapy for the treatment of glioblastoma.Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid.Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5.Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.Current and emerging EGFR therapies for glioblastoma.
P2860
Q28081685-72C6150D-83AA-4847-BF31-89120A6C79EAQ33828114-00D5DF39-CD80-4C0E-AFB3-8873611AFEF9Q33906116-94B7B7CF-5321-462E-A729-86B7B9EBE0CDQ34183374-BFED1604-A102-4E63-8967-BA0F31202B12Q34318157-ED4EEA79-FE1F-4FB9-A125-8BF4D61EDC7AQ34643252-E1B3DD6B-9A3D-4B68-A575-565EBB95AE1BQ35077747-6FD2D4B2-77B2-4238-A322-171189BED863Q35993889-E633FDDF-A486-4488-B560-E5C168304B27Q36280796-B84029DC-D8E5-494A-A2B5-CD710B918D9AQ36549443-1D99A011-CE33-4C7A-95F6-2063AC6515B4Q37214820-FE679C99-5364-4CDB-AC5D-0FB72B59BFC8Q38981383-168DF6CC-D0BF-4C42-AF06-B2A94290EE2EQ39410097-05D70CE3-C6A7-4D8F-9920-A36058B85F5CQ40103248-9D97DA0E-512B-487B-8357-72BF40925681Q42157310-21EE1EC6-1E41-4B94-9D8F-7F9D98E2E5A6Q47878958-1F327B6B-AECE-4513-BA19-A8A21DF29445
P2860
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
@en
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity.
@nl
type
label
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
@en
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity.
@nl
prefLabel
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
@en
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity.
@nl
P2093
P2860
P356
P1433
P1476
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
@en
P2093
C A Conrad
C Gomez-Manzano
F C Marini
K D Aldape
M M Alonso
V Krasnykh
P2860
P2888
P304
P356
10.1038/CGT.2008.75
P577
2008-10-17T00:00:00Z
P5875
P6179
1004506858